Author:
Wagenlehner F. M. E.,Naber K. G.
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Drilica K, Zhao X: DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 1997, 61:377–392.
2. Ehrlich-Gesellschaft P, Naber KG, Adam D: Classification of fluoroquinolones. Int J Antimicrob Agents 1998, 10:255–257.
3. Naber KG: Which fluoroquinolones are suitable for the treatment of urinary tract infections? Int J Antimicrob Agents 2001, 17:331–341.
4. Schaeffer AJ: Prostatitis: US perspective. Int J Antimicrob Agents 1999, 11:205–211.
5. Workshop Committee of the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK): Chronic Prostatitis Workshop. Bethesda, MD: December 7–8, 1995.